ClinVar Miner

Submissions for variant NM_001033855.3(DCLRE1C):c.1556C>T (p.Pro519Leu)

dbSNP: rs542791233
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000767949 SCV000898646 uncertain significance Severe combined immunodeficiency due to DCLRE1C deficiency; Histiocytic medullary reticulosis 2021-03-30 criteria provided, single submitter clinical testing DCLRE1C NM_001033855.2 exon14 p.Pro519Leu (c.1556C>T):This variant has not been reported in the literature but is present in 15/30778 South Asian alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs542791233). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. Therefore, the clinical significance of this variant is uncertain.
Labcorp Genetics (formerly Invitae), Labcorp RCV001247789 SCV001421232 uncertain significance Severe combined immunodeficiency due to DCLRE1C deficiency 2021-08-24 criteria provided, single submitter clinical testing This sequence change replaces proline with leucine at codon 519 of the DCLRE1C protein (p.Pro519Leu). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs542791233, ExAC 0.04%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 625928). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV003166029 SCV003885397 uncertain significance Inborn genetic diseases 2023-03-01 criteria provided, single submitter clinical testing The c.1556C>T (p.P519L) alteration is located in exon 14 (coding exon 14) of the DCLRE1C gene. This alteration results from a C to T substitution at nucleotide position 1556, causing the proline (P) at amino acid position 519 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Natera, Inc. RCV001825513 SCV002095366 uncertain significance Athabaskan severe combined immunodeficiency 2020-07-20 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.